Early research (Phase 1)Study completedNCT02910518
What this trial is testing
Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
Who this might be right for
Type1 Diabetes Mellitus
Sanofi 44